vs
Side-by-side financial comparison of Root, Inc. (ROOT) and Bio-Techne (TECH). Click either name above to swap in a different company.
Root, Inc. is the larger business by last-quarter revenue ($397.0M vs $295.9M, roughly 1.3× Bio-Techne). On growth, Root, Inc. posted the faster year-over-year revenue change (21.5% vs -6.4%). Over the past eight quarters, Root, Inc.'s revenue compounded faster (24.8% CAGR vs 4.2%).
Root Insurance Company is an online car insurance company operating in the United States.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
ROOT vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $397.0M | $295.9M |
| Net Profit | — | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 2.6% | 18.4% |
| Net Margin | — | 12.8% |
| Revenue YoY | 21.5% | -6.4% |
| Net Profit YoY | — | 68.3% |
| EPS (diluted) | $0.35 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $397.0M | $295.9M | ||
| Q3 25 | $387.8M | — | ||
| Q2 25 | $382.9M | $317.0M | ||
| Q1 25 | $349.4M | $316.2M | ||
| Q4 24 | $326.7M | $297.0M | ||
| Q3 24 | $305.7M | $289.5M | ||
| Q2 24 | $289.2M | $306.1M | ||
| Q1 24 | $254.9M | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $-5.4M | — | ||
| Q2 25 | $22.0M | $-17.7M | ||
| Q1 25 | $18.4M | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $22.8M | $33.6M | ||
| Q2 24 | $-7.8M | $40.6M | ||
| Q1 24 | $-6.2M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 2.6% | 18.4% | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 7.1% | -7.5% | ||
| Q1 25 | 6.8% | 12.2% | ||
| Q4 24 | 10.7% | 16.0% | ||
| Q3 24 | 11.3% | 13.8% | ||
| Q2 24 | 1.3% | 15.0% | ||
| Q1 24 | 2.1% | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | -1.4% | — | ||
| Q2 25 | 5.7% | -5.6% | ||
| Q1 25 | 5.3% | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | 7.5% | 11.6% | ||
| Q2 24 | -2.7% | 13.3% | ||
| Q1 24 | -2.4% | 16.2% |
| Q4 25 | $0.35 | $0.24 | ||
| Q3 25 | $-0.35 | — | ||
| Q2 25 | $1.29 | $-0.11 | ||
| Q1 25 | $1.07 | $0.14 | ||
| Q4 24 | $1.42 | $0.22 | ||
| Q3 24 | $1.35 | $0.21 | ||
| Q2 24 | $-0.52 | $0.26 | ||
| Q1 24 | $-0.42 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $669.3M | $172.9M |
| Total DebtLower is stronger | $200.3M | $260.0M |
| Stockholders' EquityBook value | $284.3M | $2.0B |
| Total Assets | $1.7B | $2.5B |
| Debt / EquityLower = less leverage | 0.70× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $669.3M | $172.9M | ||
| Q3 25 | $653.3M | — | ||
| Q2 25 | $641.4M | $162.2M | ||
| Q1 25 | $609.4M | $140.7M | ||
| Q4 24 | $599.3M | $177.5M | ||
| Q3 24 | $674.8M | $187.5M | ||
| Q2 24 | $667.2M | $152.9M | ||
| Q1 24 | $640.5M | $145.3M |
| Q4 25 | $200.3M | $260.0M | ||
| Q3 25 | $200.4M | — | ||
| Q2 25 | $200.1M | $346.0M | ||
| Q1 25 | $200.0M | $330.0M | ||
| Q4 24 | $200.1M | $300.0M | ||
| Q3 24 | $300.9M | $300.0M | ||
| Q2 24 | $300.1M | $319.0M | ||
| Q1 24 | $299.3M | $389.0M |
| Q4 25 | $284.3M | $2.0B | ||
| Q3 25 | $265.0M | — | ||
| Q2 25 | $244.5M | $1.9B | ||
| Q1 25 | $228.7M | $2.0B | ||
| Q4 24 | $203.7M | $2.1B | ||
| Q3 24 | $181.9M | $2.1B | ||
| Q2 24 | $151.3M | $2.1B | ||
| Q1 24 | $165.7M | $2.0B |
| Q4 25 | $1.7B | $2.5B | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | $2.6B | ||
| Q1 25 | $1.6B | $2.6B | ||
| Q4 24 | $1.5B | $2.7B | ||
| Q3 24 | $1.6B | $2.7B | ||
| Q2 24 | $1.5B | $2.7B | ||
| Q1 24 | $1.4B | $2.7B |
| Q4 25 | 0.70× | 0.13× | ||
| Q3 25 | 0.76× | — | ||
| Q2 25 | 0.82× | 0.18× | ||
| Q1 25 | 0.87× | 0.16× | ||
| Q4 24 | 0.98× | 0.14× | ||
| Q3 24 | 1.65× | 0.14× | ||
| Q2 24 | 1.98× | 0.15× | ||
| Q1 24 | 1.81× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $206.5M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $206.5M | — | ||
| Q3 25 | $57.6M | — | ||
| Q2 25 | $52.0M | $98.2M | ||
| Q1 25 | $26.8M | $41.1M | ||
| Q4 24 | $195.7M | $84.3M | ||
| Q3 24 | $49.4M | $63.9M | ||
| Q2 24 | $62.6M | $75.5M | ||
| Q1 24 | $14.5M | $81.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.3M | ||
| Q1 25 | — | $31.0M | ||
| Q4 24 | $195.3M | $77.5M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | $62.4M | $57.5M | ||
| Q1 24 | $14.3M | $64.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 29.4% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | 59.8% | 26.1% | ||
| Q3 24 | — | 18.9% | ||
| Q2 24 | 21.6% | 18.8% | ||
| Q1 24 | 5.6% | 21.3% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.0% | 3.2% | ||
| Q4 24 | 0.1% | 2.3% | ||
| Q3 24 | 0.0% | 3.2% | ||
| Q2 24 | 0.1% | 5.9% | ||
| Q1 24 | 0.1% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.36× | — | ||
| Q1 25 | 1.46× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | 2.17× | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ROOT
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
